Medical Marijuana, Inc. Subsidiaries HempMeds® and Kannaway® Become First Companies to Have CBD Products Listed in Prescribers’ Digital Reference®

SAN DIEGO, Feb. 13, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, subsidiaries HempMeds® and Kannaway® announced today that HempMeds® Real Scientific Hemp Oil™ (RSHO™) Gold Label and Kannaway® Pure Gold hemp-derived cannabidiol (CBD) products have become the first two hemp-derived CBD dietary supplements to be listed in the Prescribers’ Digital Reference® (also known as Physicians’ Desk Reference or PDR).

“It’s an honor for our portfolio of companies to have the first CBD supplements listed in the iconic PDR®, which has been a resource for healthcare providers for over 70 years,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We hope that this will help healthcare providers understand more about the benefits of our high-quality CBD products.”

“Additionally, we are conducting a brief, exploratory and collaborative clinical study to explore this product as a health-promoting dietary supplement in prediabetic individuals. When complete, the study results will be incorporated in the product dossier and published in our label content within PDR® to help healthcare providers become more familiar with the evidence-based wellness-supporting values of our hemp-derived dietary supplements,” added Dr. Titus.

PDR® has been trusted by healthcare professionals to deliver drug and supplement information for more than seven decades and remains committed to providing prescribers with access to drug labeling, safety and other clinically-relevant information.  The PDR® suite of services delivers multi-channel access to the most recognized drug information references in the U.S., interactive drug information services for EHR systems, and digital communications services via® and mobilePDR®. PDR® does not independently vet any claims provided by manufacturers, nor endorse the products contained in the PDR®.

To view the PDR’s listing for HempMeds® Real Scientific Hemp Oil™ Gold Label and Kannaway® Pure Gold, please visit

Learn more about HempMeds® RSHO™ Gold at and Kannaway® Pure Gold at

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit

To see Medical Marijuana, Inc.’s corporate video, click here.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.


These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.


Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.


The function of PDR® is solely the compilation, organization, and distribution of information on drug, natural remedy and nutritional supplements. The information included in PDR® has been provided, and paid for, by the manufacturer. PDR® does not assume, and expressly disclaims, any obligation to obtain and include any information other that what has been provided to it by the manufacturer. It should be understood that by making this material available, PDR® is not advocating or endorsing the use of this product.


Public Relations Contact:

Andrew Hard

Chief Executive Officer

CMW Media

P. 858-264-6600

[email protected]